2,5-dimethoxy-4-bromoamphetamine has been researched along with quipazine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glennon, RA | 1 |
| Dupre, A; Egan, C; Grinde, E; Hake, M; Herrick-Davis, K; Roth, BL; Teitler, M | 1 |
| Benwell, K; Bickerdike, M; Kennett, G; Knight, AR; Misra, A; Quirk, K; Revell, D | 1 |
| Done, CJ; Sharp, T | 1 |
| Breeding, M; Sanders-Bush, E | 1 |
| McKearney, JW | 1 |
| Adrien, J; Gorea, E | 1 |
1 review(s) available for 2,5-dimethoxy-4-bromoamphetamine and quipazine
| Article | Year |
|---|---|
Central serotonin receptors as targets for drug research.
Topics: Animals; Humans; Receptors, Serotonin; Research Design; Serotonin | 1987 |
6 other study(ies) available for 2,5-dimethoxy-4-bromoamphetamine and quipazine
| Article | Year |
|---|---|
Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT(2A) and 5-HT(2C) receptors.
Topics: Animals; Cell Line; Computer Simulation; GTP-Binding Proteins; Inositol Phosphates; Kinetics; Phosphatidylinositols; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Recombinant Proteins; Serotonin Receptor Agonists; Signal Transduction; Transfection; Tritium | 2000 |
Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
Topics: Binding Sites; Binding, Competitive; Cell Line; Humans; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Recombinant Proteins; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2004 |
Evidence that 5-HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo.
Topics: Amphetamines; Animals; DOM 2,5-Dimethoxy-4-Methylamphetamine; Electrophysiology; Hippocampus; Male; Neurons; Norepinephrine; p-Chloroamphetamine; Quipazine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Ritanserin; Serotonin Receptor Agonists; Spiperone; Sulpiride | 1992 |
Choroid plexus epithelial cells in primary culture: a model of 5HT1C receptor activation by hallucinogenic drugs.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Antiparkinson Agents; Cells, Cultured; Choroid Plexus; DOM 2,5-Dimethoxy-4-Methylamphetamine; Epithelial Cells; Ergolines; Hallucinogens; Male; Phosphatidylinositols; Quipazine; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Stereoisomerism | 1991 |
Serotonin-antagonist effects of 1-(1-naphthyl)piperazine on operant behavior of squirrel monkeys.
Topics: Animals; Conditioning, Operant; DOM 2,5-Dimethoxy-4-Methylamphetamine; Electroshock; Female; Food; Male; Piperazines; Quipazine; Reinforcement Schedule; Saimiri; Serotonin Antagonists | 1989 |
Serotonergic regulation of noradrenergic coerulean neurons: electrophysiological evidence for the involvement of 5-HT2 receptors.
Topics: Action Potentials; Animals; DOM 2,5-Dimethoxy-4-Methylamphetamine; Electrophysiology; Ketanserin; Locus Coeruleus; Male; Neurons; Norepinephrine; Quipazine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Synapses | 1988 |